These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 30288203)

  • 1. Endocannabinoids and related
    Tsuboi K; Uyama T; Okamoto Y; Ueda N
    Inflamm Regen; 2018; 38():28. PubMed ID: 30288203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.
    Ueda N; Tsuboi K; Uyama T
    FEBS J; 2013 May; 280(9):1874-94. PubMed ID: 23425575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.
    Ueda N; Okamoto Y; Tsuboi K
    Curr Med Chem; 2005; 12(12):1413-22. PubMed ID: 15974992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.
    Tsuboi K; Okamoto Y; Ikematsu N; Inoue M; Shimizu Y; Uyama T; Wang J; Deutsch DG; Burns MP; Ulloa NM; Tokumura A; Ueda N
    Biochim Biophys Acta; 2011 Oct; 1811(10):565-77. PubMed ID: 21801852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New players in the fatty acyl ethanolamide metabolism.
    Rahman IA; Tsuboi K; Uyama T; Ueda N
    Pharmacol Res; 2014 Aug; 86():1-10. PubMed ID: 24747663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Hum Reprod Update; 2020 Jun; 26(4):586-602. PubMed ID: 32347309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective.
    Rahman SMK; Uyama T; Hussain Z; Ueda N
    Annu Rev Nutr; 2021 Oct; 41():177-202. PubMed ID: 34115519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of endocannabinoid synthesis system.
    Wang J; Ueda N
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):112-9. PubMed ID: 19126434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
    Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the cannabinoid system for pain relief?
    Chiou LC; Hu SS; Ho YC
    Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
    Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR
    Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of endocannabinoids.
    Biernacki M; Skrzydlewska E
    Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):830-43. PubMed ID: 27516570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
    Ueda N; Tsuboi K; Uyama T; Ohnishi T
    Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Ueda N; Tsuboi K; Uyama T
    Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.
    Hu SS; Ho YC; Chiou LC
    Eur J Neurosci; 2014 Feb; 39(3):467-84. PubMed ID: 24494686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic formation of anandamide.
    Okamoto Y; Tsuboi K; Ueda N
    Vitam Horm; 2009; 81():1-24. PubMed ID: 19647106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid metabolic pathways and enzymes.
    Ligresti A; Cascio MG; Di Marzo V
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid chemical biology: a tool for the development of novel therapies.
    Petrosino S; Ligresti A; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):309-20. PubMed ID: 19457702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.